Autocrine activity of cysteinyl leukotrienes in human vascular endothelial cells: Signaling through the CysLT2 receptor

Prostaglandins and Other Lipid Mediators

Volumn 120, Issue , 2015, Pages 115-125

  Capra, Valérie ^a   Carnini, Chiara ^a   Accomazzo, Maria Rosa ^a   Di Gennaro, Antonio ^a   Fiumicelli, Marco ^a   Borroni, Emanuele ^a   Brivio, Ivan ^a   Buccellati, Carola ^a   Mangano, Paolo ^a,b   Carnevali, Silvia ^a   Rovati, Gianenrico ^a   Sala, Angelo ^a,c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c CNR Consiglio Nazionale delle Ricerche   (Italy)

Author keywords

Cell contraction; CysLT2 receptor; Cysteinyl LTs; Transcellular biosynthesis; Vascular permeability

Indexed keywords

CYSTEINE LEUKOTRIENE 2 RECEPTOR; IRALUKAST; LEUKOTRIENE A4; LEUKOTRIENE RECEPTOR; MYOSIN LIGHT CHAIN; PEPTIDOLEUKOTRIENE; POBILUKAST; PRANLUKAST; PROTEIN KINASE C; RHO FACTOR; UNCLASSIFIED DRUG; ZAFIRLUKAST; CYSTEINE; CYSTEINYL LEUKOTRIENE RECEPTOR 2; CYSTEINYL-LEUKOTRIENE; LEUKOTRIENE; LEUKOTRIENE C4; LEUKOTRIENE D4 RECEPTOR; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

ACTIN FILAMENT; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; BLOOD VESSEL PERMEABILITY; BRAIN EDEMA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CELL SHAPE; CONTROLLED STUDY; CYTOSKELETON; ENCEPHALE ISOLE; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MACROMOLECULE; NEUTROPHIL; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STRESS FIBER; TRANSIENT TRANSFECTION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULARIZATION; WEIGHT GAIN; ANIMAL; CYTOLOGY; DRUG EFFECTS; METABOLISM; PERMEABILITY; PHOSPHORYLATION;

ANIMALS; AUTOCRINE COMMUNICATION; CYSTEINE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LEUKOTRIENE A4; LEUKOTRIENE C4; LEUKOTRIENES; MYOSIN LIGHT CHAINS; NEUTROPHILS; PERMEABILITY; PHOSPHORYLATION; PROTEIN KINASE C; RATS; RECEPTORS, LEUKOTRIENE; RHO GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION; STRESS FIBERS;

EID: 84941810334     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2015.03.007     Document Type: Article

References (73)

1. A. Sala, S. Zarini, and M. Bolla Leukotrienes: lipid bioeffectors of inflammatory reactions Biochemistry 63 1998 84 92
2. V. Capra, G.E. Rovati, P. Mangano, C. Buccellati, R.C. Murphy, and A. Sala Transcellular biosynthesis of eicosanoid lipid mediators Biochim Biophys Acta 1851 2015 377 382 10.1016/j.bbalip.2014.09.002
3. A. Sala, G. Rossoni, C. Buccellati, F. Berti, G. Folco, and J. Maclouf Formation of sulphidopeptide-leukotrienes by cell-cell interaction causes coronary vasoconstriction in isolated, cell-perfused heart of rabbit Br J Pharmacol 110 1993 1206 1212
4. A. Sala, G. Rossoni, F. Berti, and et al. Monoclonal anti-CD18 antibody prevents transcellular biosynthesis of cysteinyl leukotrienes in vitro and in vivo and protects against leukotriene-dependent increase in coronary vascular resistance and myocardial stiffness Circulation 101 2000 1436 1440
5. A. Sala, G.M. Aliev, G. Rossoni, and et al. Morphological and functional changes of coronary vasculature caused by transcellular biosynthesis of sulfidopeptide leukotrienes in isolated heart of rabbit Blood 87 1996 1824 1832
6. A. Di Gennaro, C. Carnini, C. Buccellati, and et al. Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation: a role for transcellular biosynthesis of cysteinyl-leukotrienes FASEB J 18 2004 842 844 10.1096/fj.03-0599fje03-0599fje
7. S.E. Dahlen, P. Hedqvist, S. Hammarstrom, and B. Samuelsson Leukotrienes are potent constrictors of human bronchi Nature 288 1980 484 486
8. G. Folco, G. Rossoni, C. Buccellati, F. Berti, J. Maclouf, and A. Sala Leukotrienes in cardiovascular diseases Am J Respir Crit Care Med 161 2000 S112 S116 10.1164/ajrccm.161.supplement-1.ltta-22
9. V. Capra, M. Back, S.S. Barbieri, M. Camera, E. Tremoli, and G.E. Rovati Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke Med Res Rev 33 2013 364 438 10.1002/med.21251
10. L.G. Letts Leukotrienes: role in cardiovascular physiology Cardiovasc Clin 18 1987 101 113
11. A.M. Lefer Thromboxane A2 and leukotrienes are eicosanoid mediators of shock and ischemic disorders Prog Clin Biol Res 264 1988 101 114
12. C. Vigorito, A. Giordano, R. Cirillo, A. Genovese, F. Rengo, and G. Marone Metabolic and hemodynamic effects of peptide leukotriene C4 and D4 in man Int J Clin Lab Res 27 1997 178 184
13. M. Back, S.E. Dahlen, J.M. Drazen, and et al. International Union of Basic and Clinical Pharmacology. LXXXIV: leukotriene receptor nomenclature, distribution, and pathophysiological functions Pharmacol Rev 63 2011 539 584 10.1124/pr.110.004184 pii:63/3/539
14. X. Norel, and C. Brink The quest for new cysteinyl-leukotriene and lipoxin receptors: recent clues Pharmacol Ther 103 2004 81 94 10.1016/j.pharmthera.2004.05.003 pii:S0163725804000701
15. T.M. Laidlaw, and J.A. Boyce Cysteinyl leukotriene receptors, old and new; implications for asthma Clin Exp Allergy 42 2012 1313 1320 10.1111/j.1365-2222.2012.03982.x
16. S.P. Allen, A.H. Chester, P.J. Piper, A.P. Sampson, E.S. Akl, and M.H. Yacoub Effects of leukotrienes C4 and D4 on human isolated saphenous veins Br J Clin Pharmacol 34 1992 409 414
17. J.L. Ortiz, I. Gorenne, J. Cortijo, and et al. Leukotriene receptors on human pulmonary vascular endothelium Br J Pharmacol 115 1995 1382 1386
18. Y.H. Datta, M. Romano, B.C. Jacobson, D.E. Golan, C.N. Serhan, and B.M. Ewenstein Peptido-leukotrienes are potent agonists of von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells Circulation 92 1995 3304 3311
19. T.M. McIntyre, G.A. Zimmerman, and S.M. Prescott Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils Proc Natl Acad Sci U S A 83 1986 2204 2208
20. K.E. Pedersen, B.S. Bochner, and B.J. Undem Cysteinyl leukotrienes induce P-selectin expression in human endothelial cells via a non-CysLT1 receptor-mediated mechanism J Pharmacol Exp Ther 281 1997 655 662
21. L. Zhao, M.P. Moos, R. Grabner, and et al. The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm Nat Med 10 2004 966 973 10.1038/nm1099 pii:nm1099
22. B. Uzonyi, K. Lotzer, S. Jahn, and et al. Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells Proc Natl Acad Sci U S A 103 2006 6326 6331 10.1073/pnas.0601223103 pii:0601223103
23. C. Carnini, M.R. Accomazzo, E. Borroni, and et al. Synthesis of cysteinyl leukotrienes in human endothelial cells: subcellular localization and autocrine signaling through the CysLT2 receptor FASEB J 25 2011 3519 3528 10.1096/fj.10-177030
24. T. Maciag, G.A. Hoover, and R. Weinstein High and low molecular weight forms of endothelial cell growth factor J Biol Chem 257 1982 5333 5336
25. P.B. Gordon, I.I. Sussman, and V.B. Hatcher Long-term culture of human endothelial cells In Vitro 19 1983 661 671
26. M. Garcia, T. Durand, J.C. Rossi, and et al. Synthesis and biological evaluation of 14,15-dehydro-LTA(4) analog Bioorg Med Chem Lett 7 1997 105 108 10.1016/S0960-894x(96)00598-7
27. M.J. Rabiet, J.L. Plantier, Y. Rival, Y. Genoux, M.G. Lampugnani, and E. Dejana Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization Arterioscler Thromb Vasc Biol 16 1996 488 496
28. 2+ indicators with greatly improved fluorescence properties J Biol Chem 260 1985 3440 3450
29. M. De Curtis, G. Biella, M. Forti, and F. Panzica Multifocal spontaneous epileptic activity induced by restricted bicuculline ejection in the piriform cortex of the isolated guinea pig brain J Neurophysiol 71 1994 2463 2476
30. Guide for the care and use of laboratory animals 1996 National Academy Press Washington, DC
31. A. Sala, M. Bolla, S. Zarini, R. Muller-Peddinghaus, and G. Folco Release of leukotriene A4 versus leukotriene B4 from human polymorphonuclear leukocytes J Biol Chem 271 1996 17944 17948
32. A. DeLean, P.J. Munson, and D. Rodbard Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves Am J Physiol 235 1978 E97 E102
33. V. Capra, M.R. Accomazzo, S. Ravasi, and et al. Involvement of prenylated proteins in calcium signaling induced by LTD4 in differentiated U937 cells Prostaglandins Other Lipid Mediat 71 2003 235 251
34. D. Mehta, A. Rahman, and A.B. Malik Protein kinase C-alpha signals rho-guanine nucleotide dissociation inhibitor phosphorylation and rho activation and regulates the endothelial cell barrier function J Biol Chem 276 2001 22614 22620 10.1074/jbc.M101927200 pii:M101927200
35. A.J. Ridley, and A. Hall The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors Cell 70 1992 389 399 doi:0092-8674(92)90163-7
36. V. Spindler, N. Schlegel, and J. Waschke Role of GTPases in control of microvascular permeability Cardiovasc Res 87 2010 243 253 10.1093/cvr/cvq086 pii:cvq086
37. C.W. Scott, and M.F. Peters Label-free whole-cell assays: expanding the scope of GPCR screening Drug Discov Today 15 2010 704 716 10.1016/j.drudis.2010.06.008 pii:S1359-6446(10)00200-X
38. M.F. Peters, and C.W. Scott Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity J Biomol Screen 14 2009 246 255 10.1177/1087057108330115 pii:1087057108330115
39. C.J. Dunn, and K.L. Goa Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthma Drugs 61 2001 285 315
40. S.J. Keam, K.A. Lyseng-Williamson, and K.L. Goa Pranlukast: a review of its use in the management of asthma Drugs 63 2003 991 1019 pii:63105
41. C.E. Heise, B.F. O'Dowd, D.J. Figueroa, and et al. Characterization of the human cysteinyl leukotriene 2 receptor J Biol Chem 275 2000 30531 30536 10.1074/jbc.M003490200 pii:M003490200
42. S. Allen, M. Dashwood, K. Morrison, and M. Yacoub Differential leukotriene constrictor responses in human atherosclerotic coronary arteries Circulation 97 1998 2406 2413
43. M. Kamohara, J. Takasaki, M. Matsumoto, and et al. Functional characterization of cysteinyl leukotriene CysLT(2) receptor on human coronary artery smooth muscle cells Biochem Biophys Res Commun 287 2001 1088 1092 10.1006/bbrc.2001.5695 pii:S0006291X01956955
44. M. Sjostrom, A.S. Johansson, O. Schroder, H. Qiu, J. Palmblad, and J.Z. Haeggstrom Dominant expression of the CysLT2 receptor accounts for calcium signaling by cysteinyl leukotrienes in human umbilical vein endothelial cells Arterioscler Thromb Vasc Biol 23 2003 e37 e41 10.1161/01.ATV.0000082689.46538.DF pii:01.ATV.0000082689.46538.DF
45. H. Mita, M. Hasegawa, H. Saito, and K. Akiyama Levels of cysteinyl leukotriene receptor mRNA in human peripheral leucocytes: significantly higher expression of cysteinyl leukotriene receptor 2 mRNA in eosinophils Clin Exp Allergy 31 2001 1714 1723
46. K. Lotzer, R. Spanbroek, M. Hildner, and et al. Differential leukotriene receptor expression and calcium responses in endothelial cells and macrophages indicate 5-lipoxygenase-dependent circuits of inflammation and atherogenesis Arterioscler Thromb Vasc Biol 23 2003 e32 e36 10.1161/01.ATV.0000082690.23131.CB pii:01.ATV.0000082690.23131.CB
47. Y. Hui, Y. Cheng, I. Smalera, and et al. Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure Circulation 110 2004 3360 3366 10.1161/01.CIR.0000147775.50954.AA pii:01.CIR.0000147775.50954.AA
48. W. Jiang, S.R. Hall, M.P. Moos, and et al. Endothelial cysteinyl leukotriene 2 receptor expression mediates myocardial ischemia-reperfusion injury Am J Pathol 172 2008 592 602 10.2353/ajpath.2008.070834 pii:S0002-9440(10)61823-8
49. N.C. Ni, D. Yan, L.L. Ballantyne, and et al. A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice J Pharmacol Exp Ther 339 2011 768 778 10.1124/jpet.111.186031 pii:jpet.111.186031
50. T.C. Beller, A. Maekawa, D.S. Friend, K.F. Austen, and Y. Kanaoka Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice J Biol Chem 279 2004 46129 46134 10.1074/jbc.M407057200 pii:M407057200
51. F.A. Fitzpatrick, D.R. Morton, and M.A. Wynalda Albumin stabilizes leukotriene A4 J Biol Chem 257 1982 4680 4683
52. S.H. Fang, Y. Zhou, L.S. Chu, and et al. Spatio-temporal expression of cysteinyl leukotriene receptor-2 mRNA in rat brain after focal cerebral ischemia Neurosci Lett 412 2007 78 83 10.1016/j.neulet.2006.10.065 pii:S0304-3940(06)01145-1
53. X.J. Huang, W.P. Zhang, C.T. Li, and et al. Activation of CysLT receptors induces astrocyte proliferation and death after oxygen-glucose deprivation Glia 56 2008 27 37 10.1002/glia.20588
54. W.W. Sheng, C.T. Li, W.P. Zhang, and et al. Distinct roles of CysLT1 and CysLT2 receptors in oxygen glucose deprivation-induced PC12 cell death Biochem Biophys Res Commun 346 2006 19 25 10.1016/j.bbrc.2006.05.023 pii:S0006-291X(06)01065-5
55. M.L. Wang, X.J. Huang, S.H. Fang, and et al. Leukotriene D4 induces brain edema and enhances CysLT2 receptor-mediated aquaporin 4 expression Biochem Biophys Res Commun 350 2006 399 404 10.1016/j.bbrc.2006.09.057 pii:S0006-291X(06)02080-8
56. N.V. Bogatcheva, J.G. Garcia, and A.D. Verin Molecular mechanisms of thrombin-induced endothelial cell permeability Biochem 67 2002 75 84 pii:BCM67010088
57. 1 receptors Sci Rep 3 2013 3274 10.1038/srep03274
58. C.D. Ferris, R.L. Huganir, D.S. Bredt, A.M. Cameron, and S.H. Snyder Inositol trisphosphate receptor: phosphorylation by protein kinase C and calcium calmodulin-dependent protein kinases in reconstituted lipid vesicles Proc Natl Acad Sci U S A 88 1991 2232 2235
59. L. Mamedova, V. Capra, M.R. Accomazzo, and et al. CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors Biochem Pharmacol 71 2005 115 125 10.1016/j.bcp.2005.10.003 pii:S0006-2952(05)00652-0
60. G. Woszczek, L.Y. Chen, S. Alsaaty, S. Nagineni, and J.H. Shelhamer Concentration-dependent noncysteinyl leukotriene type 1 receptor-mediated inhibitory activity of leukotriene receptor antagonists J Immunol 184 2010 2219 2225 10.4049/jimmunol.0900071 pii:jimmunol.0900071
61. D.W. Hay, R.M. Muccitelli, S.S. Tucker, and et al. Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways J Pharmacol Exp Ther 243 1987 474 481
62. T. Obata, Y. Okada, M. Motoishi, N. Nakagawa, T. Terawaki, and H. Aishita In vitro antagonism of ONO-1078, a newly developed anti-asthma agent, against peptide leukotrienes in isolated guinea pig tissues Jpn J Pharmacol 60 1992 227 237
63. S. Ravasi, V. Capra, M. Mezzetti, S. Nicosia, and G.E. Rovati A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lung parenchyma Mol Pharmacol 57 2000 1182 1189
64. V. Capra, M.D. Thompson, A. Sala, D.E. Cole, G. Folco, and G.E. Rovati Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends Med Res Rev 27 2007 469 527 10.1002/med.20071
65. E. Nobili, M.D. Salvado, L. Folkersen, and et al. Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart disease PLoS ONE 7 2012 e41786 10.1371/journal.pone.0041786 pii:PONE-D-12-11324
66. G. Riccioni, V. Capra, N. D'Orazio, T. Bucciarelli, and L.A. Bazzano Leukotriene modifiers in the treatment of cardiovascular diseases J Leukoc Biol 84 2008 1374 1378 10.1189/jlb.0808476 pii:jlb.0808476
67. E. Ingelsson, L. Yin, and M. Bäck Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease J Allergy Clin Immunol 129 2012 702 707.e2 10.1016/j.jaci.2011.11.052
68. Y. Toki, N. Hieda, T. Torii, and et al. The effects of lipoxygenase inhibitor and peptidoleukotriene antagonist on myocardial injury in a canine coronary occlusion-reperfusion model Prostaglandins 35 1988 555 571
69. C.E. Hock, L.D. Beck, and L.A. Papa Peptide leukotriene receptor antagonism in myocardial ischaemia and reperfusion Cardiovasc Res 26 1992 1206 1211
70. R.A. Hahn, B.R. MacDonald, E. Morgan, and et al. Evaluation of LY203647 on cardiovascular leukotriene D4 receptors and myocardial reperfusion injury J Pharmacol Exp Ther 260 1992 979 989
71. T. Ito, Y. Toki, N. Hieda, and et al. Protective effects of a thromboxane synthetase inhibitor, a thromboxane antagonist, a lipoxygenase inhibitor and a leukotriene C4, D4 antagonist on myocardial injury caused by acute myocardial infarction in the canine heart Jpn Circ J 53 1989 1115 1121
72. T.C. Beller, D.S. Friend, A. Maekawa, B.K. Lam, K.F. Austen, and Y. Kanaoka Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis Proc Natl Acad Sci U S A 101 2004 3047 3052 10.1073/pnas.0400235101 pii:0400235101
73. Y. Jiang, L.A. Borrelli, Y. Kanaoka, B.J. Bacskai, and J.A. Boyce CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells Blood 110 2007 3263 3270 10.1182/blood-2007-07-100453 pii:blood-2007-07-100453